Teva is committed to increasing access to high-quality healthcare for people across the globe, at every stage of life. We do this by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients.
The company’s line of generic and specialty treatments is backed by our impressive global development and manufacturing capabilities, ensuring the highest quality and accessibility to medicines while reducing costs. Teva’s participation in a wide range of therapeutic areas and dosage forms is empowered by a unique integration of innovative specialty and generic research.
Some Facts and Figures
Teva was established in 1901. Our global headquarters are based in Israel.
Today we have a portfolio of more than 1,000 molecules, producing approximately 64 billion tablets and capsules a year at 66 manufacturing facilities.
We rank among the 10 top pharmaceutical companies in the world and are active in 60 countries.
Small Molecule API Market information presented through Market Scenario, Growth Overview, Geographical Analysis and Topmost Players spread over 110 pages. Avail the in-depth table of content (TOC) & market synopsis on MarketResearchFuture.com – Forecast till 2027. Posted via Industry Today. Foll…